Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Medbanks Raises $30 Million for China Oncology Database

publication date: Jul 8, 2016
Medbanks Network Technology of Beijing, a company building a China oncology database, raised $30 million in a B round led by Tencent. Established in 2014, Medbanks is developing a multi-center database that will manage and mine data that reflects China's unique patient population. It already covers the most prevalent China tumor types. The company said it will use the new capital to expand its clinical network and the database itself. Existing investors Eight Roads Ventures China, F-Prime Capital Partners and Ping An Ventures also participated in the round. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital